Peptidylarginine deiminase 4 and citrullination in health and disease

Autoimmunity Reviews

Volumn 9, Issue 3, 2010, Pages 158-160

  Anzilotti, Consuelo ^a   Pratesi, Federico ^a   Tommasi, Cristina ^a   Migliorini, Paola ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anti citrulllinated proteins peptides antibodies; Citrullination; Multiple sclerosis; Peptidylarginine deiminase 4; Rheumatoid arthritis

Indexed keywords

ALPHA ENOLASE; AUTOANTIBODY; BRAIN PROTEIN; COLLAGEN; EPSTEIN BARR VIRUS ANTIGEN; FIBRIN; PEPTIDYLARGININE DEIMINASE 4; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG; VIMENTIN;

ASIAN; CAUCASIAN; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MULTIPLE SCLEROSIS; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; CITRULLINE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROLASES; MULTIPLE SCLEROSIS;

EID: 72149084899     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.06.002     Document Type: Review

References (40)

1. Koda, and Odake. J Tokyo Chem Soc 35 (1914) 519
2. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 (2003) 395-402
3. Hoppe B., Haupl T., Gruber R., Kiesewetter H., Burmester G.R., Salama A., et al. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 8 (2006) R34
4. Chang X., Yamada R., Suzuki A., Sawada T., Yoshino S., Tokuhiro S., et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 44 (2005) 40-50
5. Asaga H., Nakashima K., Senshu T., Ishigami A., and Yamada M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol 70 (2001) 46-51
6. Vossenaar E.R., Radstake T.R., van der Heijden A., van Mansum M.A., Dieteren C., de Rooij D.J., et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63 (2004) 373-381
7. Arita K., Hashimoto H., Shimizu T., Nakashima K., Yamada M., and Sato M. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11 (2004) 777-783
8. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.M., et al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci 26 (2006) 11387-11396
9. Luo Y., Arita K., Bhatia M., Knuckley B., Lee Y.H., Stallcup M.R., et al. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45 (2006) 11727-11736
10. Dong S., Zhang Z., and Takahara H. Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by ER{alpha}-promoted transfactors AP-1, NF-Y and Sp1. Mol Endocrinol (2007) 24
11. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., et al. Histone deimination antagonizes arginine methylation. Cell 118 (2004) 545-553
12. Yamada R. Peptidylarginine deiminase type 4, anti-citrullinated peptide antibodies, and rheumatoid arthritis. Autoimm Rev 4 (2005) 201-204
13. Migliorini P., Pratesi F., Tommasi C., and Anzilotti C. The immune response to citrullinated antigens in autoimmune diseases. Autoimm Rev 4 (2005) 561-564
14. Szodoray P., Szabo Z., Kapitany A., Gyetvai A., Lakos G., Szanto S., et al. Anti-citrullinated protein/peptide antibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimm Rev (2009) 10.1016/j.autrev.2009.04.006
15. Masson-Bessiere C., Sebbag M., Girbal-Neuhauser E., Nogueira L., Vincent C., Senshu T., et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166 (2001) 4177-4184
16. Vossenaar E.R., Després N., Lapointe E., van der Heijden A., Lora M., Senshu T., et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6 (2004) R142-R150
17. Burkhardt H., Sehnert B., Bockermann R., Engstrom A., Kalden J.R., and Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35 (2005) 1643-1652
18. Kinloch A., Lundberg K., Wait R., Wegner N., Lim N.H., Zendman A.J., et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 58 (2008) 2287-2295
19. Pratesi F., Tommasi C., Anzilotti C., Chimenti D., and Migliorini P. Deiminated Epstein Barr virus nuclear antigen I is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 54 (2006) 733-741
20. Kuhn K.A., Kulik L., Tomooka B., Braschler K.J., Arend W.P., Robinson W.H., et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116 (2006) 961-973
21. van Venrooij W.J., and Pruijn G.J. An important step towards completing the rheumatoid arthritis cycle. Arthritis Res Ther 10 5 (2008) 117-119
22. Takizawa Y., Sawada T., Suzuki A., Yamada R., Inoue T., and Yamamoto K. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 34 (2005) 212-215
23. Harris M.L., Darrah E., Lam G.K., Bartlett S.J., Giles J.T., Grant A.V., et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 58 (2008) 1958-1967
24. Halvorsen E.H., Pollmann S., Gilboe I.M., van der Heijde D., Landewé R., Ødegård S., et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis 67 3 (2008) 414-417
25. Proost P., Loos T., Mortier A., Schutyser E., Gouwy M., Noppen S., et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 205 9 (2008) 2085-2097
26. Loos T., Mortier A., Gouwy M., Ronsse I., Put W., Lenaerts J.P., et al. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 112 7 (2008) 2648-2656
27. Cornelis F., Faure S., Martinez M., Prud'homme J.F., Fritz P., Dib C., et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 95 (1998) 10746-10750
28. Barton A., Bowes J., Eyre S., Spreckley K., Hinks A., John S., et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 50 (2004) 1117-1121
29. Caponi L., Petit-Teixeira E., Sebbag M., Bongiorni F., Moscato S., Pratesi F., et al. ECRAF: A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 64 (2005) 587-593
30. Ikari K., Kuwahara M., Nakamura T., Momohara S., Hara M., Yamanaka H., et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52 (2005) 3054-3057
31. Kang C.P., Lee H.S., Ju H., Cho H., Kang C., and Bae S.C. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54 (2006) 90-96
32. Burr, M.L., Naseem, H., Hinks, A., Eyre, S., Gibbons, L.J., Bowes, J., et al., PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis Online First, published on May 25, 2009 as, doi:10.1136/ard.2009.111294.
33. Moscarello M.A., Wood D.D., Ackerley C., and Boulias C. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94 (1994) 146-154
34. Wood D.D., Bilbao J.M., O'Connors P., and Moscarello M.A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40 (1996) 18-24
35. Tranquill L.R., Cao L., Ling N.C., Kalbacher H., Martin R.M., and Whitaker J.N. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler 6 (2000) 220-225
36. Moscarello M.A., Pritzker L., Mastronardi F.G., and Wood D.D. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 81 (2002) 335-343
37. Nicholas A.P., King J.L., Sambandam T., Echols J.D., Gupta K.B., McInnis C., et al. Immunohistochemical localization of citrullinated proteins in adult rat brain. J Comp Neurol 459 (2003) 251-266
38. Nicholas A.P., and Whitaker J.N. Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 37 (2002) 328-336
39. Kenealy S.J., Babron M.C., Bradford Y., Schnetz-Boutaud N., Haines J.L., Rimmler J.B., et al. A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 75 (2004) 1070-1078
40. Tommasi C., Petit-Teixeira E., Cournu-Rebeix I., Caponi L., Pierlot C., Fontaine B., et al. PADI4 gene in multiple sclerosis: a family-based association study. J Neuroimmunol 177 (2006) 142-145